STCAX
Price
$18.40
Change
-$0.07 (-0.38%)
Updated
Dec 3 closing price
Net Assets
260.49M
VIGRX
Price
$253.05
Change
+$0.01 (+0.00%)
Updated
Dec 3 closing price
Net Assets
357.2B
Interact to see
Advertisement

STCAX vs VIGRX

Header iconSTCAX vs VIGRX Comparison
Open Charts STCAX vs VIGRXBanner chart's image
Virtus Silvant Large-Cap Growth Stk I
Price$18.40
Change-$0.07 (-0.38%)
VolumeN/A
Net Assets260.49M
Vanguard Growth Index Investor
Price$253.05
Change+$0.01 (+0.00%)
VolumeN/A
Net Assets357.2B
STCAX vs VIGRX Comparison Chart in %
View a ticker or compare two or three
VS
STCAX vs. VIGRX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is STCAX is a StrongBuy and VIGRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 357B vs. STCAX (260M). VIGRX pays higher dividends than STCAX: VIGRX (0.30) vs STCAX (0.00). STCAX was incepted earlier than VIGRX: STCAX (33 years) vs VIGRX (33 years). STCAX (1.06) is less costly to investors than VIGRX (0.17). STCAX is a more actively managed with annual turnover of: 12.00 vs. VIGRX (11.00). VIGRX has a lower initial minimum investment than STCAX: VIGRX (3000) vs STCAX (100000). VIGRX annual gain was more profitable for investors over the last year : 18.49 vs. STCAX (16.23). VIGRX return over 5 years is better than : 99.11 vs. STCAX (73.42).
STCAXVIGRXSTCAX / VIGRX
Total Expense Ratio0.770.17453%
Annual Report Gross Expense Ratio1.060.17624%
Fund Existence33 years33 years-
Gain YTD18.86319.76495%
Front LoadN/AN/A-
Min. Initial Investment10000030003,333%
Min. Initial Investment IRAN/AN/A-
Net Assets260M357B0%
Annual Yield % from dividends0.000.30-
Returns for 1 year16.2318.4988%
Returns for 3 years107.91110.8297%
Returns for 5 years73.4299.1174%
Returns for 10 years70.06349.1320%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STOK30.961.15
+3.86%
Stoke Therapeutics
NEPH5.400.09
+1.69%
Nephros
TACO10.15N/A
N/A
Berto Acquisition Corp
HVIIU10.60N/A
N/A
Hennessy Capital Investmnt Corp VII
AHR50.31-0.13
-0.26%
American Healthcare REIT